EUVIMEDEUVIMED entdecken
Open Access

A Permeabilization Workflow To Enable Specific Multiplexed Profiling Using SERS Nanoparticles

Pegah Bagheri iD, Olga E Eremina iD, Nicholas Dorgan, Joshua Millstein, Cristina Zavaleta

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c08079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Pegah Bagheri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Alfred E. Mann Department of Biomedical Engineering, University of Southern California, 36- McClintock Ave, Los Angeles, California 90089, United Sta…. Hauptthemen laut MEDLINE: Breast Neoplasms, Metal Nanoparticles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIBIB NIH HHS, U.S. Department of Health and Human Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Surface-enhanced Raman scattering nanoparticles (SERS NPs) are powerful tools for cellular-specific targeting and multiplexed biomarker detection. While they have been effective in labeling extracellular receptors, their application to intracellular targets has been limited by poor membrane permeability and endosomal trapping. Here, we present an optimized permeabilization and staining strategy that enables robust intracellular targeting with SERS NPs. Using breast cancer as a model system, we focused on three clinically relevant biomarkers─human epidermal growth factor 2 (HER2), which has both extracellular and intracellular targets, and estrogen receptor (ER) and progesterone receptor (PR), which are exclusively located inside the cells─to demonstrate the ability of our platform to detect both extracellular and intracellular targets. We conjugated SERS NPs with anti-HER2 antibodies to assess specific binding efficiency across breast cancer cell lines with varying HER2 expression. Flow cytometry revealed a strong correlation between HER2 expression and the specific-to-nonspecific binding ratio, demonstrating over 100-fold specificity for HER2-overexpressing cells. Fluorescence and Raman imaging confirmed high specificity and sensitivity. To extend this approach to intracellular targets, we evaluated three permeabilization agents─Tween 20, Triton X-100, and methanol─and identified Triton X-100 as optimal. It enabled ∼160 nm SERS NPs to access the intracellular space while preserving cell viability. SERS NPs conjugated with anti-ER and anti-PR antibodies revealed significant biomarker binding without compromising cell health, revealing the capability to specifically profile intracellular biomarkers with varying expression levels of ER and PR. Furthermore, multiplexed detection was demonstrated using a cocktail of SERS NPs targeting HER2, ER, and PR in mixed cell populations, mimicking clinical scenarios such as liquid biopsies. Even when target-positive cells were present at low abundance, the NPs retained selective binding and detection capability. Overall, our findings advance the potential of SERS NPs for enhancing breast cancer diagnostics through accurate, multiplexed biomarker targeting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMetal NanoparticlesHumansSpectrum Analysis, RamanErb-b2 Receptor Tyrosine KinasesCell Line, TumorReceptors, ProgesteroneFemaleReceptors, EstrogenBiomarkers, Tumor

Stichwörter der Autor:innen

Raman spectroscopySERS nanoparticlesbreast cancer cell imagingcell permeabilizationmultiplexed imaging

Substanzen

Erb-b2 Receptor Tyrosine KinasesReceptors, ProgesteroneReceptors, EstrogenBiomarkers, TumorERBB2 protein, human

Autor:innen und Institutionen

  • Alfred E. Mann Department of Biomedical Engineering, University of Southern California, 36- McClintock Ave, Los Angeles, California 90089, United States.
  • USC Michelson Center for Convergent Bioscience, University of Southern California, 1002 Childs Way, Los Angeles, California 90089, United States.
  • Keck School of Medicine of USC, Department of Population and Public Health Sciences, 1845 N Soto St, Los Angeles, California 90032, United States.

ORCID-Profile: Pegah Bagheri, Olga E Eremina

Förderung

  • NCI NIH HHS
  • NIBIB NIH HHS
  • U.S. Department of Health and Human Services

Zitieren

APA

Bagheri, P., Eremina, O. E., Dorgan, N., Millstein, J., & Zavaleta, C. (2025). A Permeabilization Workflow To Enable Specific Multiplexed Profiling Using SERS Nanoparticles. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c08079

Vancouver

Bagheri P, Eremina OE, Dorgan N, Millstein J, Zavaleta C. A Permeabilization Workflow To Enable Specific Multiplexed Profiling Using SERS Nanoparticles. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c08079

BibTeX
@article{Bagheri2025,
  author = {Bagheri, Pegah and Eremina, Olga E and Dorgan, Nicholas and Millstein, Joshua and Zavaleta, Cristina},
  title = {A Permeabilization Workflow To Enable Specific Multiplexed Profiling Using SERS Nanoparticles},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c08079}
}
Kostenlos starten →